Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-TAT-2021-Virtual-Congress-1000x250px

Platinum Sponsor

Daiichi Sankyo Europe GmbH 

SL-Daiichi-Sankyo

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address unmet medical needs. Our 2025 Vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories.

Gold Sponsor

Loxo Oncology at Lilly

SL-Loxo-at-Lilly

For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. In 2019 Lilly created Loxo Oncology at Lilly, with the goal of rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating new medicines that unequivocally work in early clinical development and will matter to patients.

Silver Sponsors

Amgen

SL-Amgen

At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes. Amgen has been pursuing novel treatment approaches for more than 40 years. We never stop looking toward the next frontier of innovation to bring the greatest potential benefit to patients.

Astex Pharmaceuticals, Inc.

sl-astex-logo

Astex Pharmaceuticals, Inc. is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies and has a number of products being developed in collaboration with leading pharmaceutical companies. Astex is a member of the Otsuka group of companies, which also includes Otsuka Pharmaceutical, Taiho Pharmaceutical and Taiho Oncology.

Janssen EMEA

SL-Janssen

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.

Novartis

SL-Novartis

Novartis is reimagining medicine to improve people’s lives. We use innovative science and digital technologies to create transformative treatments. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines. About 109,000 people of more than 145 nationalities work at Novartis.

Pierre Fabre Laboratories

SL-Pierre-Fabre

Pierre Fabre is a global player in pharmaceuticals and dermo-cosmetics, with revenues of 2,3 billion euros in 2018 and over 11,000 employees worldwide. In 2018, Pierre Fabre dedicated 187 million euros to R&D in 4 therapeutic areas: oncology, dermatology, dermo-cosmetics and dermo-cosmetics. Its brand Eau thermal Avène is the leading dermo-cosmetic brand in the world. A unique case in France, the company is majority-owned by the Pierre Fabre Foundation, a government-recognized public-interest organization.

Educational Grants

AstraZeneca

SL-AstraZeneca

AstraZeneca has a deep-rooted heritage in oncology and offers a quickly growing portfolio of medicines with the potential to transform patients' lives. By following the science and championing the development of personalised combinations, AstraZeneca is working to redefine cancer treatment and one day eliminate cancer as a cause of death.

Bristol Myers Squibb

SL-Bristol-Myers-Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our employees work every day to transform patients’ lives through science.

F. Hoffmann-La Roche Ltd

SL-Roche

October 1, 1896, at the age of 28, Fritz Hoffmann-La Roche launched his company. Since then, Roche has grown into one of the world's leading healthcare companies. We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies

Janssen EMEA

SL-Janssen

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings